FdaApplication

ANDA 205160

Back to search

Identifiers

Properties

PropertyValue
applicant_namePHARMOBEDIENT CONSULTING LLC
application_typeANDA
approval_date2022-10-31

Products (1)

ProductActive ingredientStrengthDosage form
BORTEZOMIBBORTEZOMIB3.5MG/VIALINJECTABLE;INTRAVENOUS, SUBCUTANEOUS

1 product